Investors are weighing the benefits of the Fidelity MSCI Health Care Index ETF (FHLC) against the Invesco S&P 500 Equal Weight Health Care ETF (RSPH).
Choosing between these funds requires a balance of cost and risk tolerance. While one prioritizes low fees and market-cap growth, the other focuses on reducing the influence of a few dominant companies through equal weighting.
The Fidelity FHLC ETF utilizes a market-cap weighting strategy, which means larger companies have a greater impact on the fund's performance. This approach has delivered stronger returns compared to its equal-weight counterpart. A key advantage for FHLC is its low cost, featuring an expense ratio of 0.08% [1]. The fund provides broad exposure to the sector, holding 334 positions [3].
In contrast, the Invesco RSPH ETF employs an equal-weighting strategy. This method allocates an equal amount of capital to each company regardless of its size. This structure typically results in lower volatility because the fund is not overly dependent on the performance of a handful of industry giants. The RSPH ETF maintains a more concentrated portfolio consisting of 60 holdings [2].
The primary trade-off for investors involves diversification and cost. FHLC offers a wider net of companies and a lower expense ratio, while RSPH provides a hedge against the volatility of mega-cap stocks. The decision depends on whether an investor prefers the growth potential of the largest healthcare firms or the stability of a balanced distribution across 60 companies [2].
“Fidelity's FHLC ETF features an expense ratio of 0.08%.”
The choice between FHLC and RSPH reflects a fundamental investment decision between market-cap weighting and equal weighting. Market-cap funds like FHLC are more efficient for those seeking low costs and exposure to industry leaders, whereas equal-weight funds like RSPH protect against the risk of a few large companies dragging down the entire index.
